{"id":242,"date":"2024-03-25T17:32:00","date_gmt":"2024-03-25T17:32:00","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-news\/?p=242"},"modified":"2024-03-25T17:32:00","modified_gmt":"2024-03-25T17:32:00","slug":"drug-listing","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-news\/2024\/03\/25\/drug-listing\/","title":{"rendered":"DRUG LISTING"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">All domestic\nor foreign establishments that manufactures or commercially distributes human\ndrug and animal products within the U.S., you are subject to drug establishment\nregistration and drug listing requirements. <a href=\"https:\/\/www.fdahelp.us\/fda-drug-registration.html\">Establishment\nRegistration<\/a> and drug listings lets FDA to develop and maintain a catalog\nof all drug products marketed in the U.S. Registration information provides the\nlocations and contact information for drug establishments and determines sites\nfor inspection. Drug product listing information provides an inventory of all\ndrug products in the market with manufacturing information, which includes\ninactive ingredients incorporated into marketed drug products. The FDA depends\non this registration and listing information for controlling key programs,\nincluding post-marketing surveillance; user fee assessments; counterterrorism;\nmonitoring of drug shortages and availability; and determining products that\nare being marketed without an approved application. The electronic drug\nestablishment registration and drug listing system (eDRLS) also populates\nelectronic listing databases such as DailyMed and the National Drug Code (NDC)\nDirectory, improving the accuracy and inclusiveness of these databases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Drug\nestablishments (manufacturers\/contract manufacturers, re-packagers, re-labelers)\n&#8211; domestic and foreign &#8211; must register with the US FDA and list their products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There is no\nregistration requirement for Private Label distributors, but they must list\ntheir products under their own <a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\">NDC number<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Listing can\nbe done electronically via <a href=\"https:\/\/www.fdahelp.us\/ndc_number.html\">ESG\nportal<\/a> or FDA\u2019s CDER direct.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Listings must\nbe updated every June and December, or sooner if there are any changes. There\nis also an annual renewal period (October 1 to December 31) for certification\nwhich is called No-change certification (<a href=\"https:\/\/www.fdahelp.us\/drug-establishment-registration-renewal.html\">Blanket\nlisting submission<\/a>)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">Liberty Management Group<\/a> provides assistance with <a href=\"https:\/\/www.fdahelp.us\/fda-drug-registration.html\">drug establishment registration<\/a>, <a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\">drug listing<\/a> and <a href=\"https:\/\/www.fdahelp.us\/fda-label-review.html#1review\">label review<\/a> and US agent service to foreign drug companies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sudha S<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory Consultant<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Email : office@libertymanagement.us<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>All domestic or foreign establishments that manufactures or commercially distributes human drug and animal products within the U.S., you are subject to drug establishment registration and drug listing requirements. Establishment Registration and drug listings lets FDA to develop and maintain a catalog of all drug products marketed in the U.S. Registration information provides the locations &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-news\/2024\/03\/25\/drug-listing\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;DRUG LISTING&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[37,42],"class_list":["post-242","post","type-post","status-publish","format-standard","hentry","category-fda-registration-drug","tag-fda-drug-listing-renewal","tag-fda-drug-registration"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=242"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/242\/revisions"}],"predecessor-version":[{"id":243,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/242\/revisions\/243"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}